Kaplan Myron
SEC Form 4 insider trading activity
Kaplan Myron has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Oct 27, 2025.
On the most recent filing, Kaplan Myron is listed as Director at CorMedix Inc. Inside the rolling window, Kaplan Myron reported 1 open-market purchase totaling $276K in CRMD and no open-market sales.
Companies traded
Other insiders at CRMD
Insider Buying
$276K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kaplan Myron made?
Kaplan Myron has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Kaplan Myron trade?
Kaplan Myron has filed SEC Form 4 disclosures for 1 company, including CRMD.
When was Kaplan Myron's most recent SEC Form 4 filing?
Kaplan Myron's most recent SEC Form 4 filing on Tracefour is dated Oct 27, 2025.
What is Kaplan Myron's total buy and sell value in the current window?
Inside the rolling retention window, Kaplan Myron bought $276K and sold $0 based on SEC Form 4 filings.
What was Kaplan Myron's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 25,000 CRMD shares on 2025-10-23, worth $276K, per SEC Form 4 filings.